Molecular and Cellular Mechanisms of Aging: An Integrative Update on the Hallmarks, Emerging Regulators, and Translational Frontiers

The single biggest risk factor for cancer, neurodegeneration, cardiometabolic illness, and death globally is aging, which is a time-dependent, cumulative loss of physiological integrity. Genomic instability, telomere attrition, epigenetic changes, loss of proteostasis, impaired macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis are just a few of the interconnected molecular and cellular processes that have been identified as the "hallmarks of aging" over the past ten years. In addition to integrating recent single-cell and plasma-proteomic data demonstrating that organs and even individual cell types age asynchronously within the same organism, this review synthesizes current molecular evidence for each hallmark and suggests a novel integrative framework, the mitochondrial-epigenetic-senescence (MES) signaling axis, as a potential unifying hub through which upstream molecular damage is converted into the systemic secretory, metabolic, and inflammatory phenotype of aging. We also assess the translational pipeline of geroprotective and senotherapeutic strategies, such as senolytics and senomorphics, NAD⁺ repletion, mTOR/AMPK-targeted agents, and partial epigenetic reprogramming, with focus on their mechanistic justification, preclinical support, and current clinical evidence. These biomarkers of biological age include DNA-methylation clocks, proteomic organ-age predictors, and transcriptomic atlases. This review attempts to give a mechanistically grounded and testable paradigm to direct the logical design of the next generation of anti-aging and healthspan-extending therapies by clearly connecting upstream molecular lesions to the emergent, organism-level asynchrony of aging.